Insys Therapeutics posted a bigger-than-expected quarterly loss on Thursday due to soft demand for its flagship product Subsys, an Opioid cancer pain medication at the center of a federal probe of the company.

Last week, John Kapoor, Insys’ billionaire Founder and majority shareholder, was arrested on charges that he participated in a scheme to bribe doctors to prescribe Subsys. Kapoor resigned from the company’s board on Sunday.

Shares of Insys were up 0.6 percent at $5.12. They have fallen 44 percent since the beginning of the year.

Kapoor’s lawyer has said his client is innocent.

This article has been summarised, the full original article can be found at www.channelnewsasia.com